Why DMT breaks down so fast: MAO-A, its metabolites and a half-life of minutes

THE SHORT VERSION · SWIPE

▶ Watch it as a 20-second video

‹›

Most psychedelics last hours. DMT given by injection in a lab is largely over within half an hour. The reason is not mysterious: one enzyme, present in the gut, liver and many other tissues, takes DMT apart very quickly. Understanding that enzyme explains three things at once: why DMT is so short, why it does nothing when swallowed alone, and why ayahuasca carries interaction risks that injected DMT in a lab does not.

What is MAO, and how does it clear DMT?

Monoamine oxidase (MAO) is a family of enzymes that break down monoamines, a group of small signalling molecules that includes serotonin, noradrenaline and dopamine. There are two forms, MAO-A and MAO-B, and medicines have been developed to block each: a review of antidepressant MAO inhibitors describes both the older irreversible drugs and newer selective, reversible ones such as an MAO-A inhibitor and an MAO-B inhibitor (Shulman et al., 2013). Evidence: established.

DMT is a monoamine too, built on the same indole skeleton as serotonin. A 2018 review states that the primary route of metabolism for DMT is MAO-A, and that tryptamine and N-methyltryptamine, the molecules on the way to DMT in the body, are also MAO substrates (Barker, 2018). The same review cites further confirmation: pretreating experimental subjects with MAO-inhibiting drugs changed how DMT was handled, and a version of DMT with heavier hydrogen atoms (deuterium) at the sites MAO-A attacks lasted longer, because the enzyme works on it more slowly (Barker, 2018). Evidence: established.

What does DMT turn into? The metabolites

MAO-A converts DMT into indole-3-acetic acid (IAA), which is both the most abundant metabolite of DMT and a common end product of related tryptamines. The second most abundant metabolite is DMT-N-oxide, made by a different route; smaller amounts of N-methyltryptamine also appear. When MAO is inhibited, the balance shifts toward DMT-N-oxide and N-methyltryptamine (Barker, 2018). A modelling study of intravenous DMT in 13 healthy volunteers likewise described elimination leading to the formation of IAA as the major metabolite (Eckernäs et al., 2022).

The clearest human data come from a small 2015 study (Riba et al., 2015). Six people who already used DMT gave 24-hour urine samples in two separate sessions. In one, the study design had them swallow DMT; in the other, they smoked it (dose not reproduced here). The researchers then measured what came out:

The authors read this as a shift: when DMT is swallowed, the highly efficient MAO-dependent route dominates; in the smoked session, more DMT escaped that route and a less efficient pathway handled by cytochrome P450 (CYP) enzymes took a larger share. People whose urine showed a lower ratio of IAA to DMT-N-oxide reported stronger effects. They describe this as analogous to what happens in preparations that combine DMT with an MAO inhibitor (Riba et al., 2015). Urine recovery is an indirect measure and the sample was six people. Evidence: established for MAO-A as the main route; preliminary for the exact percentages.

How fast is DMT cleared? The half-life

A half-life is the time it takes for the concentration of a drug in the blood to fall by half. For DMT it is measured in minutes. In a 2026 University Hospital Basel study in healthy volunteers, intravenous bolus doses produced effects that peaked within the first 2 minutes and subsided completely within 12 to 30 minutes, “consistent with the short elimination half-life of approximately 6-7 min” (Erne et al., 2026). The study had a double-blind, randomized, placebo-controlled arm of 20 people and a separate open-label arm of 16. Evidence: established for the order of magnitude.

An earlier Basel trial of 27 healthy volunteers, which gave DMT as continuous infusions, found that after an infusion stopped, all effects subsided within 15 minutes. It described two phases of elimination: an early half-life of about 5 to 6 minutes, then a slower late phase of about 14 to 16 minutes after 15 to 20 minutes (Vogt et al., 2023). That matches the 1990s American work, in which the psychological effects of intravenous DMT peaked at 90 to 120 seconds and were almost completely resolved by 30 minutes, in 12 experienced volunteers (Strassman et al., 1994).

Why so fast? A population model of 13 volunteers estimated DMT clearance at 26 litres per minute, which the authors call “a high value indicating elimination of DMT to be independent of blood flow” (Eckernäs et al., 2022). Put simply, the body removes DMT about as fast as blood can deliver it to the places that break it down. One caution: these are blood measurements. Nobody has measured how fast DMT leaves the living human brain. Evidence: established for blood; unresolved for the brain.

1. DMT enters the bloodstream (in the studies above, by injection or infusion under medical supervision).
2. Effects begin within seconds and peak within about 2 minutes of a bolus.
3. MAO-A converts most DMT to indole-3-acetic acid, an inactive product; a smaller share becomes DMT-N-oxide.
4. Blood levels halve roughly every six to seven minutes after a bolus.
5. In these studies, effects were over within about 12 to 30 minutes.

Why does swallowed DMT do nothing on its own?

Because MAO gets to it first. Anything swallowed passes through the gut wall and the liver before it reaches the rest of the body, a stage called first-pass metabolism. A 1984 analysis concluded that DMT is inactive by mouth because MAO in the gut and other internal organs breaks it down (McKenna, Towers and Abbott, 1984). The 2018 review agrees that because of rapid metabolism outside the brain, DMT is converted to inactive metabolites before enough can reach the brain, and that it is orally active only together with an MAO inhibitor (Barker, 2018).

The 2015 urine study is the direct human evidence: after DMT was swallowed, no one felt any psychotropic effect, no unchanged DMT was recovered, and 97% of what was recovered was the MAO product (Riba et al., 2015). Evidence: established. It is also why traces of DMT made inside the body would not behave like a lab injection: the enzyme that clears it is everywhere too. Whether the body makes DMT at all is covered in does the brain make DMT?.

Why does that make ayahuasca pharmacologically different?

Ayahuasca is a traditional Amazonian brew that contains DMT together with a second group of compounds, the β-carboline alkaloids. The 1984 study found that β-carbolines strongly and reversibly inhibit MAO, that ayahuasca samples were extremely effective MAO inhibitors in a test-tube assay, and proposed that this protects DMT from breakdown and makes it orally active (McKenna, Towers and Abbott, 1984). A later double-blind, placebo-controlled study in 18 experienced volunteers found negligible levels of the main β-carboline in the blood and concluded that it acts mainly in the gut and liver, where MAO inhibition “would suffice to prevent first-pass metabolism of DMT” and let it reach the circulation and the brain (Riba et al., 2003). Evidence: established in outline.

That one change reshapes the whole experience. In the 2003 study, ayahuasca’s effects peaked between 1.5 and 2 hours after it was taken, and DMT blood levels peaked at about the same time (Riba et al., 2003), compared with about 2 minutes for injected DMT. Ayahuasca is therefore not “DMT, slower”: it is a mixture whose other ingredients change how the body handles DMT and many other substances. We deliberately do not describe which plants are used or how. Our ayahuasca vs DMT comparison covers timing, body effects and law in more detail.

Why does MAO inhibition create serious interaction risks?

MAO does not only clear DMT. It also clears serotonin, noradrenaline, dopamine and tyramine, a compound found in some foods. Blocking it therefore changes how the body handles many other substances. That is why prescription MAO-inhibitor antidepressants come with dietary recommendations and warnings about combining them with serotonin and noradrenaline drugs (Shulman et al., 2013). Evidence: established.

• Serotonin toxicity. Researchers warned in 1998 that combining ayahuasca’s MAO-inhibiting alkaloids with SSRI antidepressants “may induce a serotonin syndrome with potentially grave outcome” (Callaway and Grob, 1998).
• Tyramine and blood pressure. A 2024 review notes that the MAO inhibitors in ayahuasca prevent the breakdown of tyramine, and that dangerously high tyramine can cause a hypertensive crisis (White et al., 2024).
• Other drugs. A 2026 review of 219 publications on MAO inhibitors and psychoactive substances reports suspected serotonin toxicity with MAO inhibitors plus amphetamine, dextromethorphan, MDMA, meperidine, methadone and tramadol, and dangerous blood-pressure rises with stimulants such as amphetamine, methamphetamine and cocaine (Rached et al., 2026).
• DMT itself. The same review lists agitation, delirium or confusion, mania or psychosis and rhabdomyolysis (muscle breakdown) among adverse events reported when MAO inhibitors were combined with DMT, and fatalities reported with combinations involving 5-MeO-DMT, a different molecule (Rached et al., 2026).

Some balance matters here. Much of that evidence is case reports and, in the 2026 review, includes user-submitted forum reports, so it shows what can happen rather than how often (Rached et al., 2026). The 2024 review calls serotonin syndrome with ayahuasca a theoretical concern and found serious adverse effects rarely reported in healthy people in controlled settings (White et al., 2024). On food, one pharmacologist argues that modern food production has greatly reduced tyramine in most foods and that fears about MAO-inhibitor diets have been overstated, while stressing that sensitivity varies between people and care is still required (Gillman, 2018). Evidence: established for the mechanism; preliminary for how common serious harm is.

What is still unknown?

• How fast DMT is cleared from the living human brain, as opposed to the blood; it has not been measured (unresolved).
• How much MAO-A in different tissues, and differences between people, change DMT’s time course (unresolved).
• How often serious interactions with MAO inhibition happen in practice; case reports show they can, but not how often (unresolved).
• The exact share of each metabolite in larger, more varied groups than the six people in the 2015 urine study (preliminary).

The fair summary: DMT is short-acting because MAO-A breaks it down quickly and efficiently, and that same enzyme stands between a swallowed dose and the brain. Ayahuasca works by mouth because its other ingredients block MAO, which is also why it brings interaction risks that DMT on its own does not. For DMT’s time course in detail, read how long does DMT last; for the bigger picture, start with what is DMT.

Shroomverse sells mushroom products. This article is general information about how the body breaks down DMT and about MAO inhibition. It is not medical, legal or purchasing advice, and it does not recommend any product.